The Hospital Acquired Infections Testing Kits Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Hospital Acquired Infections Testing Kits Market?
The market size of the hospital acquired infections testing kits has seen robust growth in recent times. It grew from $4.54 billion in 2024 to $4.83 billion in 2025, recording a compound annual growth rate (CAGR) of 6.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Hospital Acquired Infections Testing Kits Industry?
The projected market size for the Hospital Acquired Infections Testing Kits in 2029 is expected to reach $6.78 billion, with a compound annual growth rate (CAGR) of 8.8%.
Download Your Free Sample of the 2025 Hospital Acquired Infections Testing Kits Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Hospital Acquired Infections Testing Kits Market?
The key drivers in the hospital acquired infections testing kits market are:
• Surge in instances of chronic diseases
• Overall increase in healthcare spending
• Increased government support for healthcare
• Collaborations with artificial intelligence companies in the sector
Global Market Segmentation: Identifying Major Hospital Acquired Infections Testing Kits Industry Segments
The hospital acquired infections testing kits market covered in this report is segmented –
1) By Product: Consumables And Reagents, Instruments
2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others
3) By Pathogen Type: Viral, Bacterial, Fungal
4) By Application: Drug Resistance Testing, Disease Testing
Pre-order the 2025 Hospital Acquired Infections Testing Kits Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Hospital Acquired Infections Testing Kits Market?
The key trends in the hospital acquired infections testing kits market are:
• The collaboration with artificial intelligence companies is an emerging trend.
• Leveraging support from government bodies is significantly shaping the market's future.
• The incorporation of big data into market analysis is a rising trend.
• Partnerships with other players in the market is a key emerging trend.
Who Are the Top Competitors & Leading Players in the Hospital Acquired Infections Testing Kits Market?
Major companies in the hospital acquired infections testing kits market are:
• Becton, Dickinson and Company
• Abbott Laboratories
• Cepheid
• F. Hoffmann-La Roche Ltd
• Hologic, Inc
• STERIS plc
• QIAGEN
• Meridian Bioscience Inc.
• BioMérieux SA
• Metall Zug (Belimed Group)
• Innovaccer
• JD Health
• CISCO Systems Inc
• GE Healthcare
• Honeywell Lifesciences
• Zydus Cadila
• ImmunoScience
• CPC Diagnostics
• Seegene
• SD Biosensor
• Vivacheck Lab
• Fujirebio
• Sysmex Corporation
• Philip Healthcare
• Getein Biotech
• Hangzhou Biotest Biotech
• AmonMed Biotechnology
• Beijing Tigsun Diagnostics
• Hunan Lituo Biotechnology
• Bayer AG
• Cantel Medical Corporation
• Siemens Healthineers
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the hospital-acquired infections testing kits market in 2024
